Type-I Interferon Signaling Protects against Chlamydia trachomatis Infection in the Female Lower Genital Tract.
He R, Torres CA, Wang Y, He C, Zhong G.
Infect Immun. 2023 Jun 15;91(6):e0015323. doi: 10.1128/iai.00153-23. Epub 2023 May 16.
PMID:37191510
Evidence for cGAS-STING Signaling in the Female Genital Tract Resistance to Chlamydia trachomatis Infection.
Su X, Xu H, French M, Zhao Y, Tang L, Li XD, Chen J, Zhong G.
Infect Immun. 2022 Feb 17;90(2):e0067021. doi: 10.1128/iai.00670-21. Epub 2022 Jan 3.
PMID:34978925
Etiology and Diagnosis of Pelvic Inflammatory Disease: Looking Beyond Gonorrhea and Chlamydia.
Mitchell CM, Anyalechi GE, Cohen CR, Haggerty CL, Manhart LE, Hillier SL.
J Infect Dis. 2021 Aug 16;224(12 Suppl 2):S29-S35. doi: 10.1093/infdis/jiab067.
PMID:34396407
A Machine Learning-Based Analytic Pipeline Applied to Clinical and Serum IgG Immunoproteome Data To Predict Chlamydia trachomatis Genital Tract Ascension and Incident Infection in Women.
Liu C, Mokashi NV, Darville T, Sun X, O'Connell CM, Hufnagel K, Waterboer T, Zheng X.
Microbiol Spectr. 2023 Aug 17;11(4):e0468922. doi: 10.1128/spectrum.04689-22. Epub 2023 Jun 15.